Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi ‐agent chemotherapy
British Journal of Haematology, EarlyView.
Source: British Journal of Haematology - Category: Hematology Authors: Jan Walewski
,
Andrzej Hellmann
,
Noppadol Siritanaratkul
,
Guner Hayri Ozsan
,
Muhit Ozcan
,
Suporn Chuncharunee
,
Ai Sim Goh
,
Wojciech Jurczak
,
Jan Koren
,
Ewa Paszkiewicz ‐Kozik
,
Bingxia Wang
,
Shalini Singh
,
Dirk Huebne Source Type: research
More News: Chemotherapy | Hematology | Lymphoma | Stem Cell Therapy | Stem Cells | Study | Transplants | UK Health